Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Breast and Gynecologic Cancer Research Group

Key Programs

The ASCUS/LSIL Triage Study for Cervical Cancer (ALTS)

View All  |  2010  |  2009-2000

  • Gage K. Schiffman M, Solomon D, Wheeler CM, Castle PE. Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions. Cancer Epidemiol Biomarkers Prev. 2010 19(7):1668-74.
  • Porras C, Bennett C, Safaeian M, Coseo S, Rodriguez AC, Gonzalez P, et al. Determinants of seropositivity among HPV-16/18 DNA positive young women. BMC Infect Dis. 2010 10:238.
  • Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillen D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst. 2010 102(24):315-324. 
  • Schiffman M, Solomon D. Liquid-based cytology vs. conventional cytology in detecting cervical cancer. Reply to Letter to the Editor. JAMA. 2010 303(11):1034-1035. 
  • Wacholder S, Chen BE, Wilcox A, Macones G, Gonzales P, Befano B, Hildesheim A, Rodriguez AC, Solomon D, Herrero R, Schiffman M, for the CVT Group. Risk of miscarriage in two randomized controlled trials of a bivalent accine against human papillomavirus types 16 and 18. Br Med J. 2010 340:c1666.

Back to top